While this argues against a relevant impact of the EBI2-oxysterol axis on the microbiota composition in NASH, other oxysterols might still be relevant, especially since bile acids and other products of liver metabolism can shape the gut microbiota [98]. The gene discussed is GPR183; the disease is metabolic dysfunction-associated steatohepatitis.